fosinopril has been researched along with Sensitivity and Specificity in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 7 (70.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, L; Hu, Y; Huang, J; Li, G; Si, L; Sun, X; Xue, K | 1 |
| Chiandussi, L; Milan, A; Morello, F; Mulatero, P; Paglieri, C; Rabbia, F; Veglio, F | 1 |
| George, A; Shakib, S | 1 |
| Dimkovic, N; Ivanovic, D; Jancic, B; Malenovic, A; Medenica, M | 1 |
| Ivanović, D; Janci, B; Malenović, A; Marković, S; Medenica, M | 1 |
| Chen, Y; Cui, S; Feng, F; Liu, H; Ma, M | 1 |
| Joseph, JM; Lozano, R; Perlman, S; Warren, FV | 1 |
| Brittain, HG; Conder, S; Larkin, T; Lewen, N; Schenkenberger, M | 1 |
| Jemal, M; Mulvana, DE | 1 |
| Huang, M; Jemal, M; Mao, Y; Schuster, A; Whigan, D | 1 |
1 trial(s) available for fosinopril and Sensitivity and Specificity
| Article | Year |
|---|---|
Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism.
Topics: Aldosterone; Amlodipine; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Confounding Factors, Epidemiologic; Diagnostic Tests, Routine; Doxazosin; False Negative Reactions; False Positive Reactions; Fosinopril; Humans; Hyperaldosteronism; Hypertension; Irbesartan; Middle Aged; Predictive Value of Tests; Renin; Renin-Angiotensin System; Sensitivity and Specificity; Tetrazoles; Tomography, X-Ray Computed | 2002 |
9 other study(ies) available for fosinopril and Sensitivity and Specificity
| Article | Year |
|---|---|
Simultaneous quantification of fosinopril and its active metabolite fosinoprilat in rat plasma by UFLC-MS/MS: Application of formic acid in the stabilization of an ester-containing drug.
Topics: Animals; Chromatography, High Pressure Liquid; Drug Stability; Formates; Fosinopril; Linear Models; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2015 |
Introduction to monitoring. What is what you prescribed actually doing?
Topics: Acetaminophen; Aged; Aspirin; Australia; Celecoxib; Drug Interactions; Drug Therapy, Combination; Family Practice; Female; Fosinopril; Humans; Hydrochlorothiazide; Hypertension; Monitoring, Physiologic; Osteoarthritis, Knee; Pyrazoles; Risk Assessment; Sensitivity and Specificity; Stroke; Sulfonamides | 2003 |
Development of liquid chromatographic method for fosinoprilat determination in human plasma using microemulsion as eluent.
Topics: Angiotensin-Converting Enzyme Inhibitors; Calibration; Chromatography, High Pressure Liquid; Emulsions; Fosinopril; Humans; Renal Dialysis; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 2005 |
Microemulsion liquid chromatographic method for characterisation of fosinopril sodium and fosinoprilat separation with chemometrical support.
Topics: Chromatography, High Pressure Liquid; Emulsions; Fosinopril; Reproducibility of Results; Sensitivity and Specificity | 2005 |
Development and validation of liquid chromatography-tandem mass spectrometric method for simultaneous determination of fosinopril and its active metabolite fosinoprilat in human plasma.
Topics: Angiotensin-Converting Enzyme Inhibitors; Fosinopril; Humans; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2007 |
Quantitative analysis of fosinopril sodium by capillary zone electrophoresis and liquid chromatography.
Topics: Buffers; Chromatography, Liquid; Electrophoresis; Fosinopril; Reproducibility of Results; Sensitivity and Specificity | 1995 |
The determination of palladium in fosinopril sodium (monopril) by ICP-MS.
Topics: Angiotensin-Converting Enzyme Inhibitors; Drug Contamination; Fosinopril; Linear Models; Mass Spectrometry; Palladium; Reproducibility of Results; Sensitivity and Specificity; Solvents | 1995 |
Liquid chromatographic-electrospray tandem mass spectrometric method for the simultaneous quantitation of the prodrug fosinopril and the active drug fosinoprilat in human serum.
Topics: Angiotensin-Converting Enzyme Inhibitors; Chromatography, Liquid; Fosinopril; Humans; Mass Spectrometry; Prodrugs; Reference Standards; Reproducibility of Results; Sensitivity and Specificity | 2000 |
Liquid chromatography/electrospray tandem mass spectrometry method for the quantitation of fosinoprilat in human serum using automated 96-well solid-phase extraction for sample preparation.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Chromatography, Liquid; Fosinopril; Humans; Hydrolysis; Mass Spectrometry; Quality Control; Reference Standards; Reproducibility of Results; Sensitivity and Specificity | 2000 |